These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31779634)

  • 21. Sitagliptin improved glucose assimilation in detriment of fatty-acid utilization in experimental type-II diabetes: role of GLP-1 isoforms in Glut4 receptor trafficking.
    Ramírez E; Picatoste B; González-Bris A; Oteo M; Cruz F; Caro-Vadillo A; Egido J; Tuñón J; Morcillo MA; Lorenzo Ó
    Cardiovasc Diabetol; 2018 Jan; 17(1):12. PubMed ID: 29325553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic prostacyclin agonist, ONO1301, enhances endogenous myocardial repair in a hamster model of dilated cardiomyopathy: a promising regenerative therapy for the failing heart.
    Ishimaru K; Miyagawa S; Fukushima S; Saito A; Sakai Y; Ueno T; Sawa Y
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1516-25. PubMed ID: 24229503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart specific PGC-1α deletion identifies metabolome of cardiac restricted metabolic heart failure.
    Kärkkäinen O; Tuomainen T; Mutikainen M; Lehtonen M; Ruas JL; Hanhineva K; Tavi P
    Cardiovasc Res; 2019 Jan; 115(1):107-118. PubMed ID: 29931052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression of connective tissue growth factor in cardiomyocyte of young rats with heart failure and benazepril intervention].
    Zhang Q; Yi QJ; Qian YR; Li R; Deng B; Wang Q
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):733-7. PubMed ID: 17229371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats.
    Inoue T; Inoguchi T; Sonoda N; Hendarto H; Makimura H; Sasaki S; Yokomizo H; Fujimura Y; Miura D; Takayanagi R
    Atherosclerosis; 2015 May; 240(1):250-9. PubMed ID: 25818251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.
    Keller K; Maass M; Dizayee S; Leiss V; Annala S; Köth J; Seemann WK; Müller-Ehmsen J; Mohr K; Nürnberg B; Engelhardt S; Herzig S; Birnbaumer L; Matthes J
    Cardiovasc Res; 2015 Dec; 108(3):348-56. PubMed ID: 26464333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.
    Koentges C; Pepin ME; Müsse C; Pfeil K; Alvarez SVV; Hoppe N; Hoffmann MM; Odening KE; Sossalla S; Zirlik A; Hein L; Bode C; Wende AR; Bugger H
    Basic Res Cardiol; 2018 Jan; 113(1):8. PubMed ID: 29288409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
    Soppa GK; Lee J; Stagg MA; Felkin LE; Barton PJ; Siedlecka U; Youssef S; Yacoub MH; Terracciano CM
    Cardiovasc Res; 2008 Mar; 77(4):695-706. PubMed ID: 18178572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
    Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
    Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats.
    Lee HC; Shiou YL; Jhuo SJ; Chang CY; Liu PL; Jhuang WJ; Dai ZK; Chen WY; Chen YF; Lee AS
    Cardiovasc Diabetol; 2019 Apr; 18(1):45. PubMed ID: 30935417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac retinoic acid levels decline in heart failure.
    Yang N; Parker LE; Yu J; Jones JW; Liu T; Papanicolaou KN; Talbot CC; Margulies KB; O'Rourke B; Kane MA; Foster DB
    JCI Insight; 2021 Apr; 6(8):. PubMed ID: 33724958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy.
    Sugiki T; Naya M; Manabe O; Wakasa S; Kubota S; Chiba S; Iwano H; Yamada S; Yoshinaga K; Tamaki N; Tsutsui H; Matsui Y
    JACC Cardiovasc Imaging; 2011 Jul; 4(7):762-70. PubMed ID: 21757167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart.
    Guo Y; Wang Z; Qin X; Xu J; Hou Z; Yang H; Mao X; Xing W; Li X; Zhang X; Gao F
    Cardiovasc Res; 2018 Jun; 114(7):979-991. PubMed ID: 29490017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ivabradine in Children With Dilated Cardiomyopathy and Symptomatic Chronic Heart Failure.
    Bonnet D; Berger F; Jokinen E; Kantor PF; Daubeney PEF
    J Am Coll Cardiol; 2017 Sep; 70(10):1262-1272. PubMed ID: 28859790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy.
    Kalsi KK; Smolenski RT; Pritchard RD; Khaghani A; Seymour AM; Yacoub MH
    Eur J Clin Invest; 1999 Jun; 29(6):469-77. PubMed ID: 10354207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.
    Deng W; Ednie AR; Qi J; Bennett ES
    Basic Res Cardiol; 2016 Sep; 111(5):57. PubMed ID: 27506532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart.
    Vimercati C; Qanud K; Mitacchione G; Sosnowska D; Ungvari Z; Sarnari R; Mania D; Patel N; Hintze TH; Gupte SA; Stanley WC; Recchia FA
    Am J Physiol Heart Circ Physiol; 2014 Mar; 306(5):H709-17. PubMed ID: 24414069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Independent and combined effects of liraglutide and aerobic interval training on glycemic control and cardiac protection in diabetic cardiomyopathy rats.
    Cai H; Zhou L; Liu J; Li Z; Chen S
    Biochem Biophys Res Commun; 2022 Nov; 629():112-120. PubMed ID: 36116373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide improves cardiac function in patients with type 2 diabetes and chronic heart failure.
    Arturi F; Succurro E; Miceli S; Cloro C; Ruffo M; Maio R; Perticone M; Sesti G; Perticone F
    Endocrine; 2017 Sep; 57(3):464-473. PubMed ID: 27830456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.